Advertisement

Topics

ASLAN Pharmaceuticals (ASLN) - Termination of coverage

08:24 EST 26 Nov 2018 | Edison Investment Research

Edison Investment Research - Pharmaceutical & healthcare - ASLAN Pharmaceuticals: Edison Investment Research is terminating coverage on ASLAN Pharmaceuticals (ASLN). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.
ISIN: KYG054241099

Original Article: ASLAN Pharmaceuticals (ASLN) - Termination of coverage

NEXT ARTICLE

More From BioPortfolio on "ASLAN Pharmaceuticals (ASLN) - Termination of coverage"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...